Stock Price Quote

LINCOLN PHARMACEUTICALS LTD.

NSE : LINCOLNBSE : 531633ISIN CODE : INE405C01035Industry : Pharmaceuticals & DrugsHouse : Private
BSE259.60-1.35 (-0.52 %)
PREV CLOSE ( ) 260.95
OPEN PRICE ( ) 265.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 77961
TODAY'S LOW / HIGH ( )256.90 272.05
52 WK LOW / HIGH ( )136.35 283
NSE258.70-2.3 (-0.88 %)
PREV CLOSE( ) 261.00
OPEN PRICE ( ) 264.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 258.70 (27)
VOLUME 471755
TODAY'S LOW / HIGH( ) 256.35 272.00
52 WK LOW / HIGH ( )135.25 283.45
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 20-01 1995
Management Info
Kishor M Shah - Chairman Mahendra G Patel - Managing Director
Registered Office

Address Lincoln House", Behind Satyam Complex,Science City Road,Sola,
Ahmedabad,
Gujarat-380060

Phone 079-30018000

Email info@lincolnpharma.com

Website www.lincolnpharma.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, Ahmedabad

NEWS

31Mar Intimation Of Order Passed By Hon''bl
With reference to above captioned subject, we would like to inform you t..
23Feb Announcement under Regulation 30 (LOD
We enclosed herewith the copies of published newspaper publication with..
10Feb Announcement under Regulation 30 (LOD
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
21Aug Lincoln Pharmaceuticals reports 20% ri
Lincoln Pharmaceuticals has reported results for the first quarter ended..
30Jul Lincoln Pharmaceuticals launches Vitam
With a commitment towards ‘Healthcare For All’, Lincoln Pharmaceuticals..

Financials

in Millions
QTR Dec 20 ANNUAL 20
Net Profit133.69495.63
Gross Profit 181.58 640.46
Operating Profit 199.41714.99
Net Sales 1121.923760.88

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

TTK Healthcare (BSE)
peergroup  693.85 (13.37%)
M.Cap ( in Cr)974.99
Orchid Pharma (BSE)
peergroup  1623.40 (5.00%)
M.Cap ( in Cr)6626.13
Panacea Biotec (BSE)
peergroup  351.85 (8.70%)
M.Cap ( in Cr)2155.11
Divis Lab (BSE)
peergroup  3780.00 (0.68%)
M.Cap ( in Cr)100347.12
Suven Pharma (BSE)
peergroup  543.45 (3.77%)
M.Cap ( in Cr)13834.33

Shareholding Pattern

NON-INSTITUTION 62.74%
PROMOTERS 37.26%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
No Data Found

About Lincoln Pharmaceuticals Ltd.

Lincoln Pharmaceuticals Ltd. was incorporated in the year 1995. Its today's share price is 259.6. Its current market capitalisation stands at Rs 514 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3891.71 Cr and Total Income of Rs.3882.19 Cr. The company's management includes Hashmukhbhai Patel, Niren Atinbhai Desai, Saurin J Parikh, Meha Patel, Pirabhai Suthar, Ishwarlal Patel, Arvind G Patel, Rajnikant G Patel, Ashish Patel, Munjal M Patel, Mahendra G Patel, Kishor M Shah.

It is listed on the BSE with a BSE Code of 531633 , NSE with an NSE Symbol of LINCOLN and ISIN of INE405C01035. It's Registered office is at Lincoln House", Behind Satyam Complex,Science City Road,SolaAhmedabad-380060, Gujarat. Their Registrars are ACC Ltd. It's auditors are Chandulal M Shah & Co, DK Chhajer & Co, JT Shah & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)